APPI Signs License Agreement with Celmark Direct

APPI Signs License Agreement with Celmark Direct

NEW YORK--Advanced Plant Pharmaceuticals Inc. (APPI) signed alicense agreement with Celmark Direct, a division of VitaQuest International.Under terms of the agreement, Celmark has the exclusive right to market,distribute and sell APPI's Lo-Chol supplement throughout North America withdirect response marketing. "We are extremely pleased to announce our newlicense agreement with Celmark," said David Lieberman, president and chiefexecutive officer of APPI (www.advancedplantpharm.com)."We feel confident that Celmark will exceed minimum net sales as per theagreement [and] are looking forward to a long and prosperous partnership."